China
Africa
Explore chapters and articles related to this topic
Treatment for Premenstrual Dysphoric Disorder: Navigating the Transition Through Depression and Menstrual Cycles
Published in Laura H. Choate, Depression in Girls and Women Across the Lifespan, 2019
Premenstrual Dysphoric Disorder (PMDD) is a misunderstood and often controversial diagnosis newly added to the Diagnostic and Statistical Manual of Mental Disorders in its fifth edition (DSM-5; American Psychiatric Association, 2013). PMDD is a chronic, biopsychosocial disorder that affects millions of girls and women worldwide throughout their childbearing years (Epperson et al., 2012). As exemplified in Raymond’s quote, PMDD is distinguished from other premenstrual disorders by its severity. It is characterized by severe physical, psychological, and behavioral symptoms that begin during the luteal phase of the menstrual cycle (approximately one to two weeks prior to menses) and abruptly end one to two days after the onset of menses. During the luteal phase, women with PMDD experience symptoms that will significantly impair their work, interpersonal relationships, and home life, yet they do not experience these symptoms at other times during the month.
Types of Sleep Disturbances in Women
Published in Zippi Dolev, Mordechai Zalesch, Judy Kupferman, Sleep and Women's Health, 2019
Zippi Dolev, Mordechai Zalesch, Judy Kupferman
In extreme premenstrual dysphoric disorder (PMDD), excessive sleeping can be observed as part of the general condition. Women suffering from it, as I elaborate in Chapter 5, which discusses sleep disorders during menstruation, tend to suffer for 2 weeks each month from a difficult mental state and from sleeping disturbances as part of their mental state. It is not always easy to diagnose clearly whether the excessive sleep is only linked to the hormonal changes, or whether it is a worsening of a condition related to an unstable mental state.
Herbs with Antidepressant Effects
Published in Scott Mendelson, Herbal Treatment of Major Depression, 2019
Far more work has been done in evaluating its use in the treatment of premenstrual dysphoric disorder (PMDD). Through several editions, DSM criteria for PMDD have included: unstable mood; persistent irritability or anger; anxiety, nervous tension, or feeling of being overwrought; depressive mood, feeling of hopelessness, or reduction in self -esteem; reduced interest in activities such as work, family, friends, hobbies; rapid tiring and clear lack of energy; feeling of not being able to concentrate; changes in eating behavior, such as increased appetite or craving for sweet foods; and sleep disorders such as too much sleep or sleeplessness. In addition to those emotional and neurovegetative symptoms are physical discomforts, such as tender breasts, feeling of bloating, headache, joint, or muscle pain, and weight gain.
The pharmacotherapeutic management of premenstrual dysphoric disorder
Published in Expert Opinion on Pharmacotherapy, 2023
Nancy Ciccone, Maya B. Kovacheff, Benicio N. Frey
Premenstrual dysphoric disorder (PMDD) is a prevalent medical and psychiatric condition that affects 1.2–6.4% of biological females during reproductive years [1]. This disorder may be considered one of the severe variants of physiological influence of sex steroids on the brain [2]. The constellation of symptoms associated with PMDD are triggered after ovulation and are linked to the luteal phase of the menstrual cycle [2]. Most importantly, its symptom clusters have been shown to cause severe mental distress and disrupt a woman’s functioning across multiple settings – including school and work productivity, interpersonal relationships, and social activities [3]. Unfortunately, not much education and training are provided to health practitioners, leading to missed diagnoses and sub-optimal patient care [4]. In fact, women often report that premenstrual worsening is often overlooked by health care providers [4,5]. The current scoping review seeks to provide an update on the current clinical research in PMDD, and to highlight the most up-to-date diagnostic criteria, discuss the most appropriate screening and diagnostic tools, and outline evidence-based treatment interventions. The overall goal of this article is to create a concise review for health practitioners to better equip them to recognize and treat this condition. With accurate diagnosis and treatment, full remission of symptoms and improved quality of life are possible.
Views of Dutch general practitioners about premenstrual symptoms: A qualitative interview study
Published in European Journal of General Practice, 2021
Marijke S. Labots-Vogelesang, Doreth A. M. Teunissen, Vivianne Kranenburg, Antoine L. M. Lagro-Janssen
Premenstrual syndrome (PMS) covers a broad spectrum of physiological and psychological symptoms that may disrupt women’s daily lives. Characteristic of PMS is the cyclic occurrence of symptoms in the luteal phase of the menstrual cycle [1]. There is a strict distinction between PMS and Premenstrual Dysphoric Disorder (PMDD), described in the DSM-5 as set out in Box 1. Compulsory diagnostic criteria for PMDD are that in most menstrual cycles during the past year, five (or more) of the symptoms described in Box 1 occurred during the final week before the onset of menses. These started to improve within a few days after the onset of the menses, and the symptoms were minimal or absent in the week post menses, regarding at least one of the emotional symptoms lability, irritability, depressed mood, anxiety and as physical symptoms painful breasts and bloating.
Prevalence of depressive symptoms among Turkish women experiencing premenstrual symptoms and correlated factors
Published in Alexandria Journal of Medicine, 2018
The American Psychiatric Association (2000) defines premenstrual dysphoric disorder (PMDD) as a severe form of PMS including irritability, internal tension, anger symptoms.8 PMDD has been shown to be associated with severe psychological distress, mood disorders, exacerbation of depression and, depressive disorders.9,10 However, some researchers have reported a controversial and weak relationship between major depression and premenstrual symptoms.11 Other investigators suggest that severe forms of premenstrual symptoms are “manifestations of an underlying depressive disorder”.12 In previous researches have indicated that women with PMDD and PMS have higher ratio of major depression history than women without PMDD and PMS.13–15